KALARIS THERAPEUTICS INC KLRS
COM · Common Stock · CUSIP 482929106
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersBerkeley Heights, NJ
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 18.7m as of 2025-08-06, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $2.67. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2025 | 33 |
| Q2 2025 | 31 |
Biggest buyers
| RENAISSANCE TECHNOLOGIES LLC | Added | +77.5k |
| TANG CAPITAL MANAGEMENT LLC | Added | +51.6k |
| Squarepoint Ops LLC | Added | +44.5k |
| MILLENNIUM MANAGEMENT LLC | Added | +37.5k |
| XTX Topco Ltd | New | +24.2k |
| VANGUARD GROUP INC | Added | +14.8k |
| BlackRock, Inc. | Added | +10.6k |
| RAYMOND JAMES FINANCIAL INC | New | +2.6k |
| Tower Research Capital LLC (TRC) | Added | +719 |
| MORGAN STANLEY | Added | +668 |
Biggest sellers
| GILEAD SCIENCES, INC. | Reduced | -405.5k |
| EcoR1 Capital, LLC | Sold out | -201.7k |
| Octagon Capital Advisors LP | Reduced | -121.0k |
| Woodline Partners LP | Sold out | -21.5k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -13.8k |
| BANK OF AMERICA CORP /DE/ | Reduced | -5.2k |
| UBS Group AG | Reduced | -5.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -1.3k |
| TWO SIGMA ADVISERS, LP | Reduced | -1.3k |
| JPMORGAN CHASE & CO | Reduced | -245 |
Biggest calls
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Samsara BioCapital, L.P. 13D · may seek influence -2.3 pts · filed 2026-05-22 | 54.2% |
| RTW INVESTMENTS, LP 13G · institution new · filed 2026-02-17 | 5.7% |
| Coastlands Capital LP 13G · institution new · filed 2026-10-26 | 5.7% |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 0 | — | 3 | $136.5k | $136.5k |
| Q4 2023 | 0 | — | 3 | $60.9k | $40.0k |
| Q1 2024 | 0 | — | 4 | $77.9k | — |
| Q2 2024 | 0 | — | 4 | $38.6k | — |
| Q3 2024 | 0 | — | 4 | — | — |
| Q4 2024 | 0 | — | 4 | — | — |
| Q1 2025 | 0 | — | 3 | $15.3k | — |
| Q2 2025 | 0 | — | 0 | — | — |
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| SAMSARA BIOCAPITAL, LLC 6.25% of their portfolio | 11.4m $30.6m | Unchanged |
| TANG CAPITAL MANAGEMENT LLC 0.05% of their portfolio | 360.9k $963.5k | Added +51.6k |
| Octagon Capital Advisors LP 0.21% of their portfolio | 360.0k $961.2k | Reduced -121.0k |
| GILEAD SCIENCES, INC. 0.07% of their portfolio | 317.8k $848.5k | Reduced -405.5k |
| Siren, L.L.C. 0.04% of their portfolio | 282.6k $754.5k | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 129.8k $346.7k | Added +14.8k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 96.8k $258.3k | Added +77.5k |
| Redmile Group, LLC 0.02% of their portfolio | 83.0k $221.5k | Unchanged |
| Squarepoint Ops LLC 0.00% of their portfolio | 59.1k $157.8k | Added +44.5k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 54.1k $144.4k | Added +37.5k |
| BlackRock, Inc. 0.00% of their portfolio | 38.2k $101.9k | Added +10.6k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 25.5k $68.0k | Reduced -1.3k |
| XTX Topco Ltd 0.00% of their portfolio | 24.2k $64.7k | New |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 20.3k $54.1k | Reduced -1.3k |
| RBF Capital, LLC 0.00% of their portfolio | 17.4k $46.4k | Unchanged |
| MARSHALL WACE, LLP 0.00% of their portfolio | 14.1k $37.7k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 10.7k $28.6k | Unchanged |
| FMR LLC 0.00% of their portfolio | 7.8k $20.8k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 4.1k $11.0k | Reduced -5.1k |
| RAYMOND JAMES FINANCIAL INC 0.00% of their portfolio | 2.6k $7.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.2k $5.7k | Added +719 |
| MORGAN STANLEY 0.00% of their portfolio | 2.0k $5.2k | Added +668 |
| FEDERATED HERMES, INC. 0.00% of their portfolio | 634 $1.7k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 273 $729 | Reduced -5.2k |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 170 $0 | New |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 141 $376 | Added +14 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 50 $134 | Reduced -245 |
| Parallel Advisors, LLC 0.00% of their portfolio | 49 $131 | Unchanged |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 33 $88 | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 10 $27 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |